CD24 and non-small cell lung carcinoma: Karimi-Busheri (2013) [43] further identified the CD24+/CD38− phenotype as a potential biomarker for non-small cell lung cancer, collectively suggesting that CD24 plays a significant role in lung cancer development and progression.